Phio Pharmaceuticals (PHIO) CEO Bitterman gave up 1,804 shares at $0.76 to cover taxes or an exercise price
Insider transactions reported
Robert J Bitterman (President & CEO at Phio Pharmaceuticals Corp., PHIO) reported that they gave up 1,804 shares at $0.76 to cover taxes or an exercise price on Feb 20, 2024. After these transactions the filing shows 16,490 shares held directly.
- Reporting person
- Bitterman Robert J
- Role
- President & CEO
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 20, 2024 | Shares withheld for taxes or exercise price (F) | Common stock, $0.0001 par value1, 2 | -1,804 | $0.76 | $1,371 | 16,490 direct |
Holdings before and after
- Common stock, $0.0001 par value: 18,294 to 16,490 direct
Footnotes from the filing
- 1. The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
- 2. Includes shares of common stock underlying unvested restricted stock units.
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Bitterman report in this PHIO Form 4?
Robert J Bitterman (President & CEO at Phio Pharmaceuticals Corp., PHIO) reported that they gave up 1,804 shares at $0.76 to cover taxes or an exercise price on Feb 20, 2024. After these transactions the filing shows 16,490 shares held directly.
How many PHIO shares does Bitterman hold after this filing?
The filing shows 16,490 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for PHIO
Earlier insider filings at PHIO
- Feb 21, 2024Kontulis Caitlin covered exercise/tax liability with 1,181 shares, decreasing direct ownership by 10% to 10,978 units (SEC Form 4)
- Oct 3, 2023Bitterman Robert J covered exercise/tax liability with 917 shares, decreasing direct ownership by 5% to 18,294 units (SEC Form 4)
- Jul 5, 2023SEC Form 4 filed by Bitterman Robert J
- Jun 15, 2023SEC Form 4 filed by Ferrara Robert L
- Feb 23, 2023SEC Form 4: Lockshin Curtis was granted 1,500 shares, increasing direct ownership by 88% to 3,197 units
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow PHIO and get a push notification the moment its next story breaks.